Worldwide Industry for Sepsis Diagnostics to 2025 - Featuring Abbott Diagnostics, Abionic and Beckman Coulter Among Others
Share this article Share this article ResearchAndMarkets.coms offering. Sepsis was killing over 30 million people a year with no definitive diagnostic in hand. And now the COVID-19 Pandemic has increased the sepsis death toll. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life-saving diagnostics can command a premium in the market, especiall...
Siemens Healthineers Qiagen Gmbh Biomarker Mdx Laura Wood Profiles Of Key Companies Academic Research Lab
Source: prnewswire.com